Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
Authors
Keywords
-
Journal
Pharmaceutics
Volume 15, Issue 3, Pages 998
Publisher
MDPI AG
Online
2023-03-20
DOI
10.3390/pharmaceutics15030998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
- (2023) Octavian Vasiliu Experimental and Therapeutic Medicine
- Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
- (2023) Maria Daniela Ferreira et al. Pharmaceutics
- Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain
- (2022) Shuai Zha et al. Advanced Healthcare Materials
- Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs
- (2022) Patrícia C. Pires et al. Pharmaceutics
- Characteristics of Real-World Commercially Insured Patients With Treatment-Resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States
- (2022) Swapna Karkare et al. CLINICAL THERAPEUTICS
- Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases
- (2022) Maria Inês Teixeira et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- New Insights into the Pivotal Role of the Amygdala in Inflammation-Related Depression and Anxiety Disorder
- (2022) Ping Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery
- (2022) Patrícia C. Pires et al. Pharmaceutics
- Astrocytes and major depression: The purinergic avenue
- (2022) Y.F. Zhao et al. NEUROPHARMACOLOGY
- PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
- (2022) Hashem O. Alsaab et al. Pharmaceutics
- Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
- (2022) Margarida Alberto et al. Pharmaceutics
- Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
- (2022) Patrícia C. Pires et al. Pharmaceutics
- Intranasal drug delivery: opportunities and toxicologic challenges during drug development
- (2021) Lea-Adriana Keller et al. Drug Delivery and Translational Research
- Anxiety disorders
- (2021) Brenda WJH Penninx et al. LANCET
- Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
- (2021) Weisen Zhang et al. Advanced Science
- Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
- (2021) Soraia Silva et al. Frontiers in Pharmacology
- Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
- (2021) David Lee et al. Pharmaceutics
- Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress
- (2020) Bushra Nabi et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity
- (2020) Namrah Khan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations
- (2020) Franciele Cordeiro Gabriel et al. PLoS One
- The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
- (2020) Charles B. Nemeroff AMERICAN JOURNAL OF PSYCHIATRY
- Intranasal delivery of icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity
- (2020) Dong Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
- (2020) Saba Naqvi et al. Frontiers in Neuroscience
- Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders
- (2020) Eunsoo Won et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depression
- (2020) Sonalika A. Bhattaccharjee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
- (2020) Aleksandra Zielińska et al. MOLECULES
- Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
- (2020) Madeeha Nasir et al. Frontiers in Psychiatry
- Nanoemulsions for “Nose-to-Brain” Drug Delivery
- (2019) Maria Bonferoni et al. Pharmaceutics
- Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery
- (2019) Lisa R. Volpatti et al. ACS Nano
- Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
- (2019) Jinbing Xie et al. BIOMATERIALS
- In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles
- (2019) M.D. Cayero-Otero et al. Expert Opinion on Drug Delivery
- Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
- (2018) Patrícia C. Pires et al. JOURNAL OF CONTROLLED RELEASE
- Crossing the blood-brain barrier with nanoparticles
- (2018) Yiqun Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Mechanism of intranasal drug delivery directly to the brain
- (2018) Tyler P. Crowe et al. LIFE SCIENCES
- Design and Efficacy of Nanogels Formulations for Intranasal Administration
- (2018) Blessing Aderibigbe et al. MOLECULES
- Treatment resistant depression: A multi-scale, systems biology approach
- (2018) Huda Akil et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Surface modification of PGP for a neutrophil–nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein
- (2018) Baoyu Chen et al. Acta Pharmaceutica Sinica B
- Evaluation of intranasal delivery route of drug administration for brain targeting
- (2018) Franciska Erdő et al. BRAIN RESEARCH BULLETIN
- Advanced formulations for intranasal delivery of biologics
- (2018) Julia Rohrer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Chitosan-based hydrogels: recent design concepts to tailor properties and functions
- (2017) Lisa Racine et al. POLYMER INTERNATIONAL
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry
- (2016) Katherine N. Clayton et al. Biomicrofluidics
- Microsomal cytochrome P450 as a target for drug discovery and repurposing
- (2016) Ahmed A. El-Sherbeni et al. DRUG METABOLISM REVIEWS
- Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls
- (2016) Mehmet Akif Camkurt et al. PSYCHIATRY RESEARCH
- Pharmacological effects of berberine and its derivatives: a patent update
- (2015) Yifeng Jin et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder
- (2015) Naimat Kalim Bari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
- (2014) Martin A Katzman et al. BMC Psychiatry
- cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats
- (2014) Jing Qin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug
- (2014) M. Intakhab Alam et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Chitosan in nasal delivery systems for therapeutic drugs
- (2014) Luca Casettari et al. JOURNAL OF CONTROLLED RELEASE
- Brain delivery of intranasalin situgel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment
- (2014) Prabhjot Kaur et al. JOURNAL OF DRUG TARGETING
- Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats
- (2013) Hamza Bshara et al. CARBOHYDRATE POLYMERS
- Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression
- (2013) Shadabul Haque et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
- (2012) Shadabul Haque et al. CARBOHYDRATE POLYMERS
- Drug Delivery Systems from Nose to Brain
- (2012) Ambikanandan Misra et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Neurochemical and Behavioural Changes in Rat Models of Depression
- (2011) Ivan Skelin et al. CROATICA CHEMICA ACTA
- Alginate: Properties and biomedical applications
- (2011) Kuen Yong Lee et al. PROGRESS IN POLYMER SCIENCE
- Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)
- (2010) Karsten Ulbrich et al. JOURNAL OF DRUG TARGETING
- Intranasal Clobazam Delivery in the Treatment of Status Epilepticus
- (2010) Kiruba Florence et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats
- (2009) Kundan Patil et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- On the mechanism of antidepressant-like action of berberine chloride
- (2008) Shrinivas K. Kulkarni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now